GFAP and myeloid sarcoma: More importantly, the levels of shed glycocalyx molecules in CSF positively affected the severity of NMO, MS and autoimmune GFAP astrocytopathy, and the degree of inflammation may aggravate the disruption of the blood-brain barrier.